What: Pilot grants will be awarded with funding up to $50k in total costs. The HU CFAR will provide matching funds of $10k for up to 2 applications chosen for funding. The investigator(s) will need to be a Harvard University CFAR affiliated investigator.
The same standard of medical care will be key in globally combatting the rise of drug resistant strains of HIV. Access to testing for signs of viral resistance, tailored ART regimens, and more expensive and less toxic drugs are just some of the treatment advantages in developed nations. In countries such as Kenya, Zambia, Uganda, Nigeria, Tanzania and South Africa, the alarming trend of drug resistance has nothing to do with efforts on the part of an HIV patient to adhere to medication regimens, but on other factors of access and instability. Read more about Dr. Jonathan Li Talks to the Huffington Post about the Increasing Risk of Drug Resistance